• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Maureen Testoni

Providers

HRSA seeks to fine Merck for 340B violations

HRSA is calling for Merck to get fined for cutting off sales of 340B-discounted drugs to covered entities' contract pharmacies.
Robert King Oct 25, 2022 7:20am

J&J to cut off 340B discounts to pharmacies starting in May

Mar 22, 2022 3:10pm

Judge sides with AstraZeneca in 340B contract pharmacy lawsuit

Feb 17, 2022 1:09pm

340B advocates urge federal enforcement as Amgen to cut access

Dec 2, 2021 7:05am

UCB latest drugmaker to restrict 340B drug access

Nov 24, 2021 7:40am

Drugmakers get mixed bag in rulings over 340B moves

Nov 8, 2021 3:35pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy